Skip to main content
. 2022 Feb 18;12(2):328. doi: 10.3390/biom12020328

Figure 4.

Figure 4

Unaltered RasGRP1 mRNA and protein levels in the hippocampus of schizophrenia patients. Expression levels of (a) RasGRP1 mRNA in the post-mortem hippocampus of SCZ-affected patients (SCZ) (n = 19) and control subjects (CTRL) (n = 18). Quantification of western blot analysis of (b) RasGRP1 protein levels in the total homogenates of post-mortem hippocampus of SCZ-affected patients (SCZ) (n = 20) and control subjects (CTRL) (n = 20). The variations of RasGRP1 protein levels in patients affected by SCZ are expressed as percentage (%) of the control subjects. All markers were normalized to GAPDH for variations in loading and transfer; (c) representative images of immunoblots of RasGRP1 performed in the hippocampus of SCZ patients and control subjects. Each dot represents value from a single subject. Unpaired t-test was performed in all analyses reported.